ICU Medical Corp (ICUI) - Forward Price-to-Revenue Multiple

icumed.com (ICUI) - corporate logo

ICU Medical, Inc. (ICUI) develops secure infusion systems integrated into resuscitation protocols. The future P/S trend for ICU Medical, Inc. (ICUI) visualizes these successes, with 0.50 recorded as the baseline value. Business revenues rely on hospital budgets and hospitalization volumes. The current course is focused on optimizing production and updating long-term agreements with medical networks.

ICUI icumed.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/13/2026

ICU Medical Inc. - analytical breakdowns and key metrics (ICUI)

- market price and analyst price targets:
General company analysis:ICUI (ICU Medical)
Original product of icumed.com

The conservatism of the hospital sector and high barriers to staff retraining ensure the stability of ICU Medical, Inc. (ICUI) market positions. The projected P/S trend reflects market value dynamics relative to expected revenue, allowing investors to distinguish fundamental growth from speculative euphoria. An increase in this ratio signals an overvaluation, creating the risk of losses should the implementation rate of medical systems slow down.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Merit Medical Corp - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio XRAY (dentsplysirona.com)|LMAT - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio AtriCure Inc ATRC|STAA: Forward P/S Multiple|NAGE - Market Cap to Expected Sales Ratio|ZIMV (ZimVie Inc.) - Forward P/S Multiple|Forward Price-to-Revenue Multiple angiodynamics.com (ANGO)|Forward Price-to-Revenue Multiple CERS (Cerus)|Forward P/S Multiple Alpha Teknova (TKNO)|Monogram Technologies Inc - Forward Price-to-Revenue Multiple|Forward Price to Sales STSS|INFU - Price-to-Projected Revenue Ratio|utahmed.com (UTMD) - Forward Price-to-Revenue Multiple|KRMD: Forward P/S Multiple|Market Cap to Future Revenue Ratio Nyxoah SA (NYXH)|MBOT (Microbot Medical Inc) - Forward P/S Multiple|Market Cap to Projected Revenue PDEX (Pro-Dex Inc.)|Forward P/S Multiple ZTEK|Market Cap to Expected Sales Ratio elutia.com|Forward P/S Multiple MLSS (Milestone Scientific Inc.)|NXGL - Forward Price-to-Revenue Multiple|Retractable Tech - Forward P/S Multiple|HBIO - Forward P/S Multiple|Femasys Inc. (FEMY) - Price-to-Projected Revenue Ratio|MHUA (Meihua Medical Technologies Co., Ltd.) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple POAI|CJMB: Forward Price to Sales|Forward P/S Multiple ATRI|Market Cap to Expected Sales Ratio NeuroMetrix Corporation